EQL Pharma Investor Relations Material
Latest events
Q1 25/26
EQL Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from EQL Pharma
Access all reports
EQL Pharma AB engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. It specializes in the treatment of male infertility by proactive production and sale of medicines under its owned trademarks to end consumers, private actors as well as public hospitals and pharmacies. The company was founded in 2006 and is based in Lund, Sweden.
Key slides for EQL Pharma
CMD 2025
EQL Pharma
ABGSC Investor Days
EQL Pharma
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
EQL
Country
🇸🇪 Sweden